⌘K

Home/Filings/4/0001104659-23-044711

4//SEC Filing

Bradley Greg 4

Accession 0001104659-23-044711

CIK 0001815903other

View on SEC.gov Company Profile

Filed

Apr 11, 8:00 PM ET

Accepted

Apr 12, 6:00 PM ET

Size

5.4 KB

Accession

0001104659-23-044711

Insider Transaction Report

Form 4

Period: 2023-04-10

Petros Pharmaceuticals, Inc.PTPI

Director

Transactions

Award
Stock Option (Right to Buy)
2023-04-10+39,000→ 39,000 total
Exercise: $0.99Exp: 2033-04-10→ Common Stock (39,000 underlying)

Footnotes (1)

[F1]The stock options will vest on the one-year anniversary of the date of grant, provided that the Reporting Person has continued to provide services to Petros Pharmaceuticals, Inc. (the "Company") through the vesting date.

Documents

1 file

4
tm2312600-2_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Petros Pharmaceuticals, Inc.

CIK 0001815903

Entity typeother

Related Parties

1

filerCIK 0001833504

Filing Metadata

Form type: 4
Filed: Apr 11, 8:00 PM ET
Accepted: Apr 12, 6:00 PM ET
Size: 5.4 KB

View on SEC.gov